biopharma

matt.sulli42 matt.sulli42 PRO TKAI, 15, Long , 15 days ago
TKAI: tkai long risk/reward 1.64
33 0 4
TKAI, 15 Long
tkai long risk/reward 1.64
Tkai massive upside potential. In other words, buy between .99 and current price 1.06 and aim to get out in the 1.2's. Current price is the high point of first wave up (the XA)..price descended appropriately (1--> .618) for support, and moved higher between the 1.21 and 1.41 exetension of XA. The following ...
matt.sulli42 matt.sulli42 PRO GALE, D, a month ago
GALE: Fib numbers in a major downtrend?? GALE
15 0 2
GALE, D
Fib numbers in a major downtrend?? GALE
One more retracement up followed by a downtrend would make fib numbers work for GALE price action. Food for thought
matt.sulli42 matt.sulli42 PRO BSPM, 15, 2 months ago
BSPM: BSPM elliot wave 5 around 6.25
15 0 1
BSPM, 15
BSPM elliot wave 5 around 6.25
It may already be too late to cash in on BSPM
matt.sulli42 matt.sulli42 PRO MSTX, 15, 2 months ago
MSTX: MSTX consolidation at 11
20 2 3
MSTX, 15
MSTX consolidation at 11
P to consolidate @ .11 before next major move?
matt.sulli42 matt.sulli42 PRO MSTX, 60, 2 months ago
MSTX: Why MSTX may not rise until at least 10/3
15 0 2
MSTX, 60
Why MSTX may not rise until at least 10/3
With Section 8 Rules, I don't expect the shares to fall much lower than they already have. But, with Fib Time Trend, it looks like shares may not rise until at least Oct 3, maybe early next week? But with the possibility of being removed if shares fall to 6, I can't imagine them falling much more than another penny ...
Kantardziski Kantardziski PRO SPHS, M, Long , 2 months ago
SPHS: Sophiris (SPHS) Multi-month Ascending Broadening Wedge - Bullish
68 0 1
SPHS, M Long
Sophiris (SPHS) Multi-month Ascending Broadening Wedge - Bullish
SPHS is in a multi-year ABW and with the latest partial decline, in addition to other important fundamental and technical factors, it will likely breakout upwards - To infinity and beyond!!
sum1 sum1 PRO IBB, W, Short , 4 months ago
IBB: IBB BIOTECH
63 0 1
IBB, W Short
IBB BIOTECH
RECENTLY most of the biotech companies are doing bad but somehow this ETF is going up. I saw weakness in technical analysis of monthly charts but weekly and daily needs to go down before shorting. Think this IBB bull will be ashort lived and once broken it will be a free fall zone. Leap options for short side will ...
andrew.berg andrew.berg PRO LGND, D, Long , 6 months ago
LGND: Ligand Pharmaceuticals best choise in the Biopharma Industry
21 0 2
LGND, D Long
Ligand Pharmaceuticals best choise in the Biopharma Industry
Fundamentals: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than ...
Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out